Emergent BioSolutions (EBS) Income from Discontinued Operations (2015 - 2016)
Emergent BioSolutions (EBS) posted Income from Discontinued Operations of $5.1 million for Q4 2016, up 436.03% on a QoQ basis from $952000.0 in Q3 2016, and up 155.81% year-over-year from $2.0 million in Q1 2016.
Powered by 
Analysis
Emergent BioSolutions (EBS) Income from Discontinued Operations (2015 - 2016) Analysis & Trends
Emergent BioSolutions has reported Income from Discontinued Operations for 2 years, with the latest figure at $5.1 million in Q4 2016.
- On a quarterly basis, Income from Discontinued Operations rose 155.81% year-over-year to $5.1 million in Q4 2016; TTM through Sep 2017 was $5.1 million, a 120.42% increase from a year earlier, with the FY2016 full-year figure at -$10.7 million, up 62.52% from the prior year.
- Income from Discontinued Operations was $5.1 million for Q4 2016 at Emergent BioSolutions, up from $952000.0 in the prior quarter.
- The five-year high for Income from Discontinued Operations was $5.1 million in Q4 2016, with the low at -$9.1 million in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | - |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | - |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 8.00 Mn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | - |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | - |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 5.10 Mn |
| Sep 30, 2016 | 952,000.00 |
| Jun 30, 2016 | -8.91 Mn |
| Mar 31, 2016 | -7.90 Mn |
| Dec 31, 2015 | -9.14 Mn |
| Sep 30, 2015 | -5.15 Mn |
| Jun 30, 2015 | -8.47 Mn |
| Mar 31, 2015 | -5.79 Mn |
API Access
Emergent BioSolutions Income from Discontinued Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-discontinued-operations", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();